Cybin Inc. (HELP) vs Verastem, Inc. (VSTM)

Cybin Inc. and Verastem, Inc. are both Biotechnology companies. Cybin Inc. and Verastem, Inc. are of similar size ($835.9M and $807.3M). Cybin Inc. has the higher net margin (0.00% vs −231.6%) and the lower return on invested capital (−137.9% vs 0.00%). Across the 14 metrics below, Cybin Inc. leads on 8 and Verastem, Inc. on 6.

Valuation

Metric HELP VSTM Biotechnology median
P/E n/m n/m 8.50
P/S n/m 9.89 9.71
P/B 2.28 17.32 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 9.29 9.21
Earnings yield (38.49%) (28.44%) (33.15%)
Free cash flow yield (25.89%) (18.73%) (25.50%)

Profitability

Metric HELP VSTM Biotechnology median
Gross margin 0.00% 86.35% 65.16%
Operating margin 0.00% (182.57%) 0.00%
Net margin 0.00% (231.59%) 0.00%
Free cash flow margin 0.00% (185.31%) 0.00%
Return on equity (86.94%) (471.16%) (56.36%)
Return on assets (72.78%) (100.65%) (48.04%)
Return on invested capital (137.88%) 0.00% 0.00%

Growth

Metric HELP VSTM Biotechnology median
Revenue growth (TTM) — 472.89% 6.02%
EPS growth (last fiscal year) (5.72%) 17.49% 30.26%
Revenue growth, 5-year CAGR — 12.11% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HELP VSTM Biotechnology median
Debt to equity 0.00 1.48 0.00
Current ratio 10.97 2.25 4.72
Net debt to EBITDA 1.10 0.76 0.96

Dividend

Metric HELP VSTM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HELP VSTM Biotechnology median
Market cap 807.31m 835.90m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack